Initial trial results bolster evidence for Telix’s brain cancer treatment

Telix Pharmaceuticals plans to accelerate development of its radiopharmaceutical to treat the most aggressive form of brain cancer after encouraging … Read More

The post Initial trial results bolster evidence for Telix’s brain cancer treatment appeared first on Stockhead.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *